RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.
RayThera has raised $110.0M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
RayThera's investors include OrbiMed, Foresite Capital, Qiji Investment.
RayThera is headquartered in San Diego, United States.
RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.
RayThera is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RayThera — Funding & Investors." VCBacked, April 4, 2025, https://www.vcbacked.co/company/raythera. Accessed September 10, 2026.
VCBacked. (2025). RayThera — Funding & Investors. Retrieved September 10, 2026, from https://www.vcbacked.co/company/raythera
{{cite web |title=RayThera — Funding & Investors |url=https://www.vcbacked.co/company/raythera |website=VCBacked |access-date=September 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated